Cancer Therapeutics (CT) Program
The overarching goals of the Cancer Therapeutics (CT) program are to advance
the translation of ideas through:
1) the development and translation of new therapeutic agents; 2) biotechnology
approaches (i.e., new therapies or drug-delivery vehicles, innovative
imaging technologies, and data analysis systems) to enhance new cancer
treatments and diagnostics; and 3) to develop and initiate innovative
clinical trials with focus on priority cancers.
The thematic areas and specific aims of the CT Program are:
- Drug Development and Delivery: To foster the development and translation of new therapeutic agents.
- Biotechnology: To utilize biotechnology to develop new cancer treatments and diagnostics.
- Developmental Therapeutics: To develop and initiate innovative clinical trials with a focus on priority cancers.
-
.png)
Kathleen Moore, MD
Program Co-Leader
-
.png)
Lacey McNally, PhD
Program Co-Leader
